KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Revenue (2016 - 2025)

Opko Health's Revenue history spans 16 years, with the latest figure at $148.5 million for Q4 2025.

  • For Q4 2025, Revenue fell 19.16% year-over-year to $148.5 million; the TTM value through Dec 2025 reached $606.9 million, up 7.68%, while the annual FY2025 figure was $606.9 million, 14.9% down from the prior year.
  • Revenue reached $148.5 million in Q4 2025 per OPK's latest filing, down from $151.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $545.2 million in Q1 2021 to a low of $1.0 million in Q3 2021.
  • Average Revenue over 5 years is $209.7 million, with a median of $180.8 million recorded in 2022.
  • Peak YoY movement for Revenue: crashed 99.77% in 2021, then soared 17874.4% in 2022.
  • A 5-year view of Revenue shows it stood at $401.3 million in 2021, then plummeted by 53.82% to $185.3 million in 2022, then fell by 1.85% to $181.9 million in 2023, then grew by 0.95% to $183.6 million in 2024, then dropped by 19.16% to $148.5 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Revenue are $148.5 million (Q4 2025), $151.7 million (Q3 2025), and $156.8 million (Q2 2025).